Céline Pulcini is Full Professor of Infectious Disease in Nancy, France. Her main research interest lies in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics. Professor Pulcini is Secretary of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antibiotic Policies. She is or has recently served also as Expert for the National Antibiotic Plan of the French Ministry of Health, the ECDC and the WHO. She is a member of the Executive Committee of the French Infectious Diseases Society (SPILF) and she coordinates the SPILF Antimicrobial Stewardship working group. In addition to this, Professor Pulcini is a partner in the European Innovative Medicines Initiative project ‘DRIVE-AB’. As well as serving as an Associate Editor for the journal Clinical Microbiology and Infection, Professor Pulcini has also authored or co-authored over 130 international publications. She received in 2017 the ESCMID Young Investigator Award. Onder Ergonul, MD, MPH has been a professor of Infectious Diseases and Clinical Microbiology at Koç University, School of Medicine since 2011. He graduated from Hacettepe University School of Medicine in 1989 and completed his residency in 1996 in the Infectious Diseases and Clinical Microbiology department of Ankara University in Ankara, Turkey. He received his Master of Public Health degree from Harvard University School of Public Health in 2003. In 2000-2002, he worked as a research fellow in the Clinical Epidemiology division of the Infectious Diseases Department at the University of Utah, School of Medicine, USA. He is the editor of a book on Crimean-Congo Hemorrhagic Fever (2007, Springer). He received the Public Health Scientific award of Turkish Medical Association in 2007. He has been the president of the Turkish Society of Clinical Microbiology and Infectious Diseases since 2013. He has been the associate editor of Clinical Microbiology and Infection, official journal of the European Society of Clinical Microbiology and Infectious Diseases since 2013. He was elected as the member of Science Academy of Turkey in 2013. Fusun Can, MD Can is an associate professor of medical microbiology at the Koc University School of Medicine. She is specialized in the epidemiology of emerging bacterial pathogens, antibiotic resistance mechanisms and biofilm related infections. She graduated from Hacettepe University School of Medicine in 1989 and completed her residency in 1996 at Ankara University, Department of Microbiology and Clinical Microbiology in Ankara,Turkey. She worked as a research fellow in the Department of Microbiology at the University of Florida School of Medicine, USA. Before joining Koc University, she was the director of the Department of Medical Microbiology at Baskent University, in Ankara. She is responsible for the Microbiology and Biosafety Level III Laboratory at Koc University. Prof. Bojana Beović, MD, PhD graduated at Medical School University in Ljubljana where she obtained her master degree and PhD. She was further educated in pharmacology at the University of Zagreb, Croatia and at The University of Wisconsin Hospital and Clinics. From 2006 to 2009 she was the president of the Health Council at the Ministry of Health of Slovenia. From 2012 to 2017, she was the President of the Educational Council at the Medical Chamber of Slovenia. Currently, she is the head of the ID Consultancy Service at UMC Ljubljana, and vice chair of the Department of Infectious Diseases. Since 2004 she is the president of the Slovenian Society of Chemotherapy and since 2005 the vice-president of the Intersectoral Coordination Mechanism for Prudent Use of Antimicrobials at the Ministry of Health. Since 2008 she is the head of the Antibiotic Committee in UMC Ljubljana. Since 2015 she is the chair of the European Society of Clinical Microbiology and Infectious diseases (ESCMID) Study group for Antibiotic policies (ESGAP). She actively participates in several European level initiatives in the field of antimicrobial resistance and stewardship.She is full professor of infectious diseases at the Medical School, University of Ljubljana. She was the organizer and co-organizer of several international and national scientific meetings and educational courses, and the author of several national antimicrobial guidelines and handbooks on antimicrobial therapy. Her current focus of interest in research is antibiotic stewardship, infections in surgery, and infections with multiple resistant bacteria.

• Section A: The Global Picture of Antimicrobial Use and Resistance1. The Global Crisis of Antimicrobial Resistance2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance3. Quality Indicators and Quantity Metrics of Antibiotic UseSection B: AMS Strategies4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship10. The Role of Pharmacists11. The Roles of Nurses in Antimicrobial Stewardship12. Antifungal StewardshipSection C: AMS in Specific Clinical Settings13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care14. Antimicrobial Stewardship: What to Tell the Patients and the General Public15. Antimicrobial Stewardship in Long-Term Care Facilities16. Antimicrobial Stewardship in ICU17. Antimicrobial Stewardship in Hematology Patients18. AMS in an Era of Multidrug-Resistant BacteriaSection D: AMS Experiences Around the World19.1: AMS Initiatives and Policies: The International Picture19.2: Missions and Objectives of EUCIC and ESGAP19.3: Antimicrobial Stewardship in Latin America19.4: Antimicrobial Stewardship in Australia19.5: Antimicrobial Stewardship in Austria19.6: Antimicrobial Stewardship in Belgium19.7: Antimicrobial Stewardship in Bulgaria19.8: Antimicrobial Stewardship in Croatia19.9: Antimicrobial Stewardship in England19.10: Antimicrobial Stewardship in France19.11: Antimicrobial Stewardship in Germany19.12: Antimicrobial Stewardship in Greece19.13: Antimicrobial Stewardship in India19.14: Antimicrobial Stewardship in Israel19.15: Antimicrobial Stewardship in Italy19.16: Antimicrobial Stewardship in Japan19.17: Antibiotic Stewardship in the Netherlands19.18: Antimicrobial Stewardship in Scotland19.19: Antimicrobial Stewardship in Slovenia19.20: Antimicrobial Stewardship in South Africa19.21: Antimicrobial Stewardship in Argentina19.22: Antimicrobial Stewardship in Spain19.23: Antibiotic Stewardship in Sweden19.24: Antimicrobial Stewardship in Switzerland19.25: Antimicrobial Stewardship in Turkey19.26: Antimicrobial Stewardship in the United StatesSection E: Research and Perspectives20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"

Céline Pulcini is Full Professor of Infectious Disease in Nancy, France. Her main research interest lies in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics. Professor Pulcini is Secretary of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antibiotic Policies. She is or has recently served also as Expert for the National Antibiotic Plan of the French Ministry of Health, the ECDC and the WHO. She is a member of the Executive Committee of the French Infectious Diseases Society (SPILF) and she coordinates the SPILF Antimicrobial Stewardship working group. In addition to this, Professor Pulcini is a partner in the European Innovative Medicines Initiative project ‘DRIVE-AB’. As well as serving as an Associate Editor for the journal Clinical Microbiology and Infection, Professor Pulcini has also authored or co-authored over 130 international publications. She received in 2017 the ESCMID Young Investigator Award. Onder Ergonul, MD, MPH has been a professor of Infectious Diseases and Clinical Microbiology at Koç University, School of Medicine since 2011. He graduated from Hacettepe University School of Medicine in 1989 and completed his residency in 1996 in the Infectious Diseases and Clinical Microbiology department of Ankara University in Ankara, Turkey. He received his Master of Public Health degree from Harvard University School of Public Health in 2003. In 2000-2002, he worked as a research fellow in the Clinical Epidemiology division of the Infectious Diseases Department at the University of Utah, School of Medicine, USA. He is the editor of a book on Crimean-Congo Hemorrhagic Fever (2007, Springer). He received the Public Health Scientific award of Turkish Medical Association in 2007. He has been the president of the Turkish Society of Clinical Microbiology and Infectious Diseases since 2013. He has been the associate editor of Clinical Microbiology and Infection, official journal of the European Society of Clinical Microbiology and Infectious Diseases since 2013. He was elected as the member of Science Academy of Turkey in 2013. Fusun Can, MD Can is an associate professor of medical microbiology at the Koc University School of Medicine. She is specialized in the epidemiology of emerging bacterial pathogens, antibiotic resistance mechanisms and biofilm related infections. She graduated from Hacettepe University School of Medicine in 1989 and completed her residency in 1996 at Ankara University, Department of Microbiology and Clinical Microbiology in Ankara,Turkey. She worked as a research fellow in the Department of Microbiology at the University of Florida School of Medicine, USA. Before joining Koc University, she was the director of the Department of Medical Microbiology at Baskent University, in Ankara. She is responsible for the Microbiology and Biosafety Level III Laboratory at Koc University. Prof. Bojana Beović, MD, PhD graduated at Medical School University in Ljubljana where she obtained her master degree and PhD. She was further educated in pharmacology at the University of Zagreb, Croatia and at The University of Wisconsin Hospital and Clinics. From 2006 to 2009 she was the president of the Health Council at the Ministry of Health of Slovenia. From 2012 to 2017, she was the President of the Educational Council at the Medical Chamber of Slovenia. Currently, she is the head of the ID Consultancy Service at UMC Ljubljana, and vice chair of the Department of Infectious Diseases. Since 2004 she is the president of the Slovenian Society of Chemotherapy and since 2005 the vice-president of the Intersectoral Coordination Mechanism for Prudent Use of Antimicrobials at the Ministry of Health. Since 2008 she is the head of the Antibiotic Committee in UMC Ljubljana. Since 2015 she is the chair of the European Society of Clinical Microbiology and Infectious diseases (ESCMID) Study group for Antibiotic policies (ESGAP). She actively participates in several European level initiatives in the field of antimicrobial resistance and stewardship.She is full professor of infectious diseases at the Medical School, University of Ljubljana. She was the organizer and co-organizer of several international and national scientific meetings and educational courses, and the author of several national antimicrobial guidelines and handbooks on antimicrobial therapy. Her current focus of interest in research is antibiotic stewardship, infections in surgery, and infections with multiple resistant bacteria.

• Section A: The Global Picture of Antimicrobial Use and Resistance1. The Global Crisis of Antimicrobial Resistance2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance3. Quality Indicators and Quantity Metrics of Antibiotic UseSection B: AMS Strategies4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship10. The Role of Pharmacists11. The Roles of Nurses in Antimicrobial Stewardship12. Antifungal StewardshipSection C: AMS in Specific Clinical Settings13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care14. Antimicrobial Stewardship: What to Tell the Patients and the General Public15. Antimicrobial Stewardship in Long-Term Care Facilities16. Antimicrobial Stewardship in ICU17. Antimicrobial Stewardship in Hematology Patients18. AMS in an Era of Multidrug-Resistant BacteriaSection D: AMS Experiences Around the World19.1: AMS Initiatives and Policies: The International Picture19.2: Missions and Objectives of EUCIC and ESGAP19.3: Antimicrobial Stewardship in Latin America19.4: Antimicrobial Stewardship in Australia19.5: Antimicrobial Stewardship in Austria19.6: Antimicrobial Stewardship in Belgium19.7: Antimicrobial Stewardship in Bulgaria19.8: Antimicrobial Stewardship in Croatia19.9: Antimicrobial Stewardship in England19.10: Antimicrobial Stewardship in France19.11: Antimicrobial Stewardship in Germany19.12: Antimicrobial Stewardship in Greece19.13: Antimicrobial Stewardship in India19.14: Antimicrobial Stewardship in Israel19.15: Antimicrobial Stewardship in Italy19.16: Antimicrobial Stewardship in Japan19.17: Antibiotic Stewardship in the Netherlands19.18: Antimicrobial Stewardship in Scotland19.19: Antimicrobial Stewardship in Slovenia19.20: Antimicrobial Stewardship in South Africa19.21: Antimicrobial Stewardship in Argentina19.22: Antimicrobial Stewardship in Spain19.23: Antibiotic Stewardship in Sweden19.24: Antimicrobial Stewardship in Switzerland19.25: Antimicrobial Stewardship in Turkey19.26: Antimicrobial Stewardship in the United StatesSection E: Research and Perspectives20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"

Céline Pulcini is Full Professor of Infectious Disease in Nancy, France. Her main research interest lies in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics. Professor Pulcini is Secretary of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antibiotic Policies. She is or has recently served also as Expert for the National Antibiotic Plan of the French Ministry of Health, the ECDC and the WHO. She is a member of the Executive Committee of the French Infectious Diseases Society (SPILF) and she coordinates the SPILF Antimicrobial Stewardship working group. In addition to this, Professor Pulcini is a partner in the European Innovative Medicines Initiative project ‘DRIVE-AB’. As well as serving as an Associate Editor for the journal Clinical Microbiology and Infection, Professor Pulcini has also authored or co-authored over 130 international publications. She received in 2017 the ESCMID Young Investigator Award. Onder Ergonul, MD, MPH has been a professor of Infectious Diseases and Clinical Microbiology at Koç University, School of Medicine since 2011. He graduated from Hacettepe University School of Medicine in 1989 and completed his residency in 1996 in the Infectious Diseases and Clinical Microbiology department of Ankara University in Ankara, Turkey. He received his Master of Public Health degree from Harvard University School of Public Health in 2003. In 2000-2002, he worked as a research fellow in the Clinical Epidemiology division of the Infectious Diseases Department at the University of Utah, School of Medicine, USA. He is the editor of a book on Crimean-Congo Hemorrhagic Fever (2007, Springer). He received the Public Health Scientific award of Turkish Medical Association in 2007. He has been the president of the Turkish Society of Clinical Microbiology and Infectious Diseases since 2013. He has been the associate editor of Clinical Microbiology and Infection, official journal of the European Society of Clinical Microbiology and Infectious Diseases since 2013. He was elected as the member of Science Academy of Turkey in 2013. Fusun Can, MD Can is an associate professor of medical microbiology at the Koc University School of Medicine. She is specialized in the epidemiology of emerging bacterial pathogens, antibiotic resistance mechanisms and biofilm related infections. She graduated from Hacettepe University School of Medicine in 1989 and completed her residency in 1996 at Ankara University, Department of Microbiology and Clinical Microbiology in Ankara,Turkey. She worked as a research fellow in the Department of Microbiology at the University of Florida School of Medicine, USA. Before joining Koc University, she was the director of the Department of Medical Microbiology at Baskent University, in Ankara. She is responsible for the Microbiology and Biosafety Level III Laboratory at Koc University. Prof. Bojana Beović, MD, PhD graduated at Medical School University in Ljubljana where she obtained her master degree and PhD. She was further educated in pharmacology at the University of Zagreb, Croatia and at The University of Wisconsin Hospital and Clinics. From 2006 to 2009 she was the president of the Health Council at the Ministry of Health of Slovenia. From 2012 to 2017, she was the President of the Educational Council at the Medical Chamber of Slovenia. Currently, she is the head of the ID Consultancy Service at UMC Ljubljana, and vice chair of the Department of Infectious Diseases. Since 2004 she is the president of the Slovenian Society of Chemotherapy and since 2005 the vice-president of the Intersectoral Coordination Mechanism for Prudent Use of Antimicrobials at the Ministry of Health. Since 2008 she is the head of the Antibiotic Committee in UMC Ljubljana. Since 2015 she is the chair of the European Society of Clinical Microbiology and Infectious diseases (ESCMID) Study group for Antibiotic policies (ESGAP). She actively participates in several European level initiatives in the field of antimicrobial resistance and stewardship.She is full professor of infectious diseases at the Medical School, University of Ljubljana. She was the organizer and co-organizer of several international and national scientific meetings and educational courses, and the author of several national antimicrobial guidelines and handbooks on antimicrobial therapy. Her current focus of interest in research is antibiotic stewardship, infections in surgery, and infections with multiple resistant bacteria.

• Section A: The Global Picture of Antimicrobial Use and Resistance1. The Global Crisis of Antimicrobial Resistance2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance3. Quality Indicators and Quantity Metrics of Antibiotic UseSection B: AMS Strategies4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship10. The Role of Pharmacists11. The Roles of Nurses in Antimicrobial Stewardship12. Antifungal StewardshipSection C: AMS in Specific Clinical Settings13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care14. Antimicrobial Stewardship: What to Tell the Patients and the General Public15. Antimicrobial Stewardship in Long-Term Care Facilities16. Antimicrobial Stewardship in ICU17. Antimicrobial Stewardship in Hematology Patients18. AMS in an Era of Multidrug-Resistant BacteriaSection D: AMS Experiences Around the World19.1: AMS Initiatives and Policies: The International Picture19.2: Missions and Objectives of EUCIC and ESGAP19.3: Antimicrobial Stewardship in Latin America19.4: Antimicrobial Stewardship in Australia19.5: Antimicrobial Stewardship in Austria19.6: Antimicrobial Stewardship in Belgium19.7: Antimicrobial Stewardship in Bulgaria19.8: Antimicrobial Stewardship in Croatia19.9: Antimicrobial Stewardship in England19.10: Antimicrobial Stewardship in France19.11: Antimicrobial Stewardship in Germany19.12: Antimicrobial Stewardship in Greece19.13: Antimicrobial Stewardship in India19.14: Antimicrobial Stewardship in Israel19.15: Antimicrobial Stewardship in Italy19.16: Antimicrobial Stewardship in Japan19.17: Antibiotic Stewardship in the Netherlands19.18: Antimicrobial Stewardship in Scotland19.19: Antimicrobial Stewardship in Slovenia19.20: Antimicrobial Stewardship in South Africa19.21: Antimicrobial Stewardship in Argentina19.22: Antimicrobial Stewardship in Spain19.23: Antibiotic Stewardship in Sweden19.24: Antimicrobial Stewardship in Switzerland19.25: Antimicrobial Stewardship in Turkey19.26: Antimicrobial Stewardship in the United StatesSection E: Research and Perspectives20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"